Cytodyn Inc (CYDY)

[misiu143]

C-20 , well , we could be , and imo , would be if we Gilead , but otherwise ,
It was only phase 2 , only 84 patients in the study ,
we had before only 65 patients in eIND , this in medicine is really a very small number..

So I kind of understand the point ..and they didn't stop us , we may do phase 3 with around 100 patients , we dont need 1000s as others need to prove a point ,
and NEWS2 will be our primary , and they know we will succeed.

And I do believe all this will help us to get EUA in our CD12 , and full approval about 5-6 months later.( Remdesivir got full approval about 5 months after EUA )

Just IMO.